Abstract:Background Triple-negative breast cancer (TNBC) is a category of breast cancer characterized with high molecular heterogeneity. Owing to the lack of effective therapeutic strategies, patients with TNBC have a poor prognosis. Paris saponin VII (PSVII), a steroidal saponin extracted from the rhizome of Trichillium tschonoskii Maxim, exhibits excellent anti-cancer activity in a variety of solid tumors. However, the role and potential mechanism of PSVII against TNBC remain unexplored. Purpose This study aimed to elucidate the therapeutic effects of PSVII against TNBC and explore the potential mechanism of action. Methods We combined the analysis of public single-cell sequencing data with weighted gene co-expression network analysis (WGCNA) to identity differentially expressed genes (DEGs) that distinguished malignant and normal epithelial cells in TNBC. Subsequently, the biological features of DEGs in TNBC were evaluated. Gene set enrichment analysis (GSEA) was used to define potential pathways associated with the DEGs. The pharmacological activity of PSVII for TNBC was evidenced via in vitro and in vivo experiments, and molecular docking, molecular dynamics (MD), surface plasmon resonance (SPR) assay and western blotting were employed to confirm the relative mechanisms. Results Single-cell sequencing and WGCNA revealed STMN1 as a pivotal biomarker of TNBC. STMN1 overexpression in TNBC was associated with poor patient prognosis. GSEA revealed a significant accumulation of STMN1 within the MAPK signaling pathway. Furthermore, In vitro experiments showed that PSVII showed significantly suppressive actions on the proliferation, migration and invasion abilities for TNBC cells, while inducing apoptosis. Molecular docking, MD analysis and SPR assay indicated a robust interaction between PSVII and the MEK protein. Western blotting revealed that PSVII may inhibit tumor progression by suppressing the phosphorylation of MEK1/2 and the downstream phosphorylation of ERK1/2 and STMN1. Intraperitoneal injection of PSVII (10 mg/kg) notably reduced tumor growth by 71.26 % in a 4T1 xenograft model. Conclusion In our study, the systems biology method was used to identify potential therapeutic targets for TNBC. In vitro and in vivo experiments demonstrated PSVII suppresses cancer progression by targeting the MEK/ERK/STMN1 signaling axis. For the first time, the inhibition of STMN1 phosphorylation has been indicated as a possible mechanism for the anticancer effects of PSVII. These results emphasize the potential value of PSVII as a promising anti-cancer drug candidate for further development in the field of TNBC therapeutics.

Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway.

Paris Saponin VII Reverses Chemoresistance in Breast MCF-7/ADR Cells.

Prevention of hip fractures: risk factor modification.

Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis

Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells

Paris saponin VII, a direct activator of AMPK, induces autophagy and exhibits therapeutic potential in non-small-cell lung cancer

Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP-2/9 production via the p38 MAPK signaling pathway

Paris saponin VII promotes ferroptosis to inhibit breast cancer via Nrf2/GPX4 axis

Depletion of the Proteasome Subunit Psma7 Inhibits Colorectal Cancer Cell Tumorigenicity and Migration

Paris Saponin VII Enhanced the Sensitivity of HepG2/ADR Cells to ADR Via Modulation of PI3K/AKT/MAPK Signaling Pathway.

Total saponins from Rhizoma Panacis Majoris inhibit proliferation, induce cell cycle arrest and apoptosis and influence MAPK signalling pathways on the colorectal cancer cell

Cytotoxic steroidal glycosides from the rhizomes of Paris polyphylla var. yunnanensis

PP9, a steroidal saponin, induces G2/M arrest and apoptosis in human colorectal cancer cells by inhibiting the PI3K/Akt/GSK3β pathway

Polyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways

Inhibitory effects of Paris saponin I, II, VI and VII on HUVEC cells through regulation of VEGFR2, PI3K/AKT/mTOR, Src/eNOS, PLCγ/ERK/MERK, and JAK2-STAT3 pathways

The Extract of Paris Polyphylla Exerts Apoptotic Induction and Synergic Antiproliferative Effect with Anticancer Drugs in SMMC-7721 Human Liver Cancer Cells

Saikosaponin A, a Triterpene Saponin, Suppresses Angiogenesis and Tumor Growth by Blocking VEGFR2-Mediated Signaling Pathway

Paris Saponin I Induces Apoptosis Via Increasing the Bax/Bcl-2 Ratio and Caspase-3 Expression in Gefitinib-Resistant Non-Small Cell Lung Cancer in Vitro and in Vivo.

Saponins From Paris forrestii (Takht.) H. Li Display Potent Activity Against Acute Myeloid Leukemia by Suppressing the RNF6/AKT/mTOR Signaling Pathway

Paris Saponins Enhance Radiosensitivity in A Gefitinib-Resistant Lung Adenocarcinoma Cell Line by Inducing Apoptosis and G(2)/M Cell Cycle Phase Arrest

Steroidal saponin components and their cancer cell cytotoxicity from Paris rugosa